| Serial Number | 90981041 |
| Word Mark | RG |
| Filing Date | Tuesday, August 24, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, June 11, 2024 |
| Registration Number | 7414310 |
| Registration Date | Tuesday, June 11, 2024 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, August 23, 2022 |
| Description of Mark | The mark consists of a stylized illustration of the letters "R" and "G", which illustration is also meant to be a stylized presentation of the DNA double helix structure. |
| Goods and Services | Medical, biological, pharmaceutical, and veterinary preparations containing polypeptide encoding nucleic acids for the prevention and treatment of rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders and reproductive disorders;medical, biological, pharmaceutical, and veterinary preparations for medical and pharmaceutical use, namely, preparations for preventing and treating rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders, and reproductive disorders; RNA-based therapeutics and therapeutic agents for in vitro preparation and in vivo, ex vivo, or on vivo delivery to cell sites; cell-based immunotherapeutic treatment by way of genetically modified cells, medicated serums for the treatment of rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders and reproductive disorders; attenuated viruses and particles similar to viruses, namely, encapsulated nucleic acids for the treatment of rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders and reproductive disorders; diagnostic reagents and diagnostic preparations for medical purposes; chemical reagents used for medical or veterinary purposes; biochemical reagents used for medical or veterinary purposes for the treatment of cancer, treatment of immunological diseases, and treatment of infectious diseases; adjuvants for medical purposes; macromolecules, namely, nucleic acid sequences and proteins, used for medical and veterinary purposes; a full line of pharmaceuticals, vaccines, medicines, biologics, biotherapeutics, biosimilars and therapeutics for the treatment of infectious diseases and cancer; vaccines; a full line of pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars and therapeutics for the treatment of infectious diseases and cancer |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Sunday, October 10, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | Friday, February 9, 2024 |
| First Use In Commerce Date | Friday, February 9, 2024 |
| Party Name | RinuaGene Biotechnology Co., Ltd. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Suzhou, Jiangsu 215000 CN |
| Party Name | RinuaGene Biotechnology Co., Ltd. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Suzhou, Jiangsu 215000 CN |
| Party Name | RinuaGene Biotechnology Co., Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Suzhou, Jiangsu 215000 CN |
| Event Date | Event Description |
| Friday, August 27, 2021 | NEW APPLICATION ENTERED |
| Sunday, October 10, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, October 12, 2021 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Thursday, May 26, 2022 | ASSIGNED TO EXAMINER |
| Thursday, June 9, 2022 | NON-FINAL ACTION WRITTEN |
| Thursday, June 9, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, June 9, 2022 | NON-FINAL ACTION E-MAILED |
| Friday, July 15, 2022 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED |
| Friday, July 15, 2022 | WITHDRAWAL OF ATTORNEY GRANTED |
| Friday, July 15, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, July 15, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, July 15, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, July 15, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, July 18, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, August 3, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, August 23, 2022 | PUBLISHED FOR OPPOSITION |
| Tuesday, August 23, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 18, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, March 20, 2023 | SOU TEAS EXTENSION RECEIVED |
| Monday, March 20, 2023 | SOU EXTENSION 1 FILED |
| Monday, March 20, 2023 | SOU EXTENSION 1 GRANTED |
| Monday, March 20, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, March 20, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, March 20, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, March 22, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, April 17, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Monday, April 17, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, April 17, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, October 4, 2023 | ASSIGNED TO EXAMINER |
| Wednesday, October 11, 2023 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, October 11, 2023 | SOU EXTENSION 2 FILED |
| Wednesday, October 11, 2023 | SOU EXTENSION 2 GRANTED |
| Friday, October 13, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, April 12, 2024 | SOU EXTENSION 3 FILED |
| Friday, April 12, 2024 | DIVISIONAL REQUEST RECEIVED |
| Friday, April 12, 2024 | USE AMENDMENT FILED |
| Friday, April 12, 2024 | SOU TEAS EXTENSION RECEIVED |
| Friday, April 12, 2024 | TEAS REQUEST TO DIVIDE RECEIVED |
| Friday, April 12, 2024 | TEAS STATEMENT OF USE RECEIVED |
| Tuesday, April 23, 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Wednesday, May 8, 2024 | SOU EXTENSION 3 GRANTED |
| Wednesday, May 8, 2024 | DIVISIONAL PROCESSING COMPLETE |
| Wednesday, May 8, 2024 | STATEMENT OF USE PROCESSING COMPLETE |
| Thursday, May 9, 2024 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Thursday, May 9, 2024 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Thursday, May 9, 2024 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Tuesday, June 11, 2024 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, June 11, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Thursday, May 9, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |